Skip to main
PBM
PBM logo

Psyence Biomedical Ltd (PBM)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy PBM Stock

About Psyence Biomedical Ltd (PBM)

Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Market cap$412.7K
Today's volume6.89K
Revenue (TTM)
Avg. daily volume85.28K
EBITDA (TTM)
Open$4.54
Price / earnings ratio-0.30x
Today's range$4.38 - $4.73
Debt / equity
52 week range$2.92 - $699.19
5 year debt / equity
Beta (LTM)1.77x
Interest coverage-51.98x
Dividend & yield$0.00 (0.00%)
Current ratio0.64x
Ex-dividend date
Next earningsJun 27, 2025
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for PBM stock is $412.7K

The current P/E ratio for PBM stock is -0.3

The 52-week high for PBM stock is $699.19. The current PBM stock price $undefined is 100.00% below its 52-week high

The 52-week low for PBM stock is $2.92. The current PBM stock price $undefined has increased 100.00% from its 52-week low

No, the PBM stock does not pay dividends to its shareholders

How to buy PBM stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PBM stock

    Navigate to the Explore page. Then, type PBM into the search bar. When you see PBM stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PBM stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Psyence Biomedical Ltd Stock Earnings

The value each PBM share was expected to gain vs. the value that each PBM share actually gained.

PBM (PBM) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, PBM's earnings per share (EPS) was $0. PBM is expected to release next earnings on 06/27/2025, with an earnings per share (EPS) estimate of $0.

Buy PBM Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.